Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-12-28

Clinical Trial Update: Phase 2 AMG 714 in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial of AMG 714 for rheumatoid arthritis has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMG 714

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED